Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: A search for the early precursors of papillary cancer

American Journal of Pathology

Volumn 160, Issue 6, 2002, Pages 2157-2167

  Fusco, Alfredo ^a   Chiappetta, Gennaro ^b   Hui, Pei ^e   Garcia Rostan, Ginesa ^d   Golden, Lauren ^e   Kinder, Barbara K ^e   Dillon, Deborah A ^e   Giuliano, Ada ^b   Cirafici, Anna Maria ^a   Santoro, Massimo ^a   Rosai, Juan ^c   Tallini, Giovanni ^e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN PATCHED; PROTEIN RET; TUBULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE REARRANGEMENT; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID NODULE; THYROID PAPILLARY CARCINOMA;

EID: 0036087975     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61164-9     Document Type: Article

References (37)

1. The significance of non-toxic nodules: Final report of a 15 year study of the incidence of thyroid malignancy
2. Thyroid cancer in thyroid nodules: Finding a needle in the haystack
3. Follow-up evaluation and clinical course of patients with benign nodular thyroid disease
4. Tumors of the thyroid gland
5. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas
6. Involvement of RET oncogene in human tumors: Specificity of RET activation to thyroid tumors
7. Molecular characterization of RET/PTC3: A novel rearranged version of the RET protooncogene in a human thyroid papillary carcinoma
8. A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers
9. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B
10. Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade
11. Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma
12. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas
13. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes
14. RET/PTC oncogene activation is an early event in thyroid carcinogenesis
15. A new human species of aldolase A mRNA from fibroblasts
16. Potentiation of the malignant phenotype of the undifferentiated ARO thyroid cell line by insertion of the bcl-2 gene
17. Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome
18. The macrofollicular variant of papillary thyroid carcinoma: A study of 17 cases
19. Ret oncogene protein expression in papillary thyroid carcinoma and related lesions
20. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia
21. RET receptor expression in thyroid follicular epithelial cell-derived tumors
22. Expression and alternative splicing of c-RET RNA in papillary thyroid carcinomas
23. RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH
24. Clonality of thyroid nodules in sporadic goiter
25. Genetic heterogeneity of benign thyroid lesions. Static and flow cytometry, karyotyping and in situ hybridization analysis
26. Thyroid gland
27. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia
28. Guest editorial: Two proposals regarding the terminology of thyroid tumors
29. TPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method
30. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation
31. Ret/ptc rearrangements in thyroid nodules: Studies in irradiated, malignant and benign thyroid lesions in children and adults
32. Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis
33. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: Biological, phenotypic, and clinical implications
34. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells
35. Thyroid lesions in children and adolescents after the Chernobyl disaster: Implications for the study of radiation tumorigenesis
36. Clonal origin of non-medullary thyroid tumours assessed by non-random X-chromosome inactivation
37. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles